Stockscreener 앱 받기
2.775
0.54%
-0.015
시간 외 거래:
2.94
0.165
+5.95%
전일 마감가:
$2.79
열려 있는:
$2.81
하루 거래량:
1.36M
Relative Volume:
0.99
시가총액:
$284.66M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-3.5127
EPS:
-0.79
순현금흐름:
$-47.97M
1주 성능:
-13.01%
1개월 성능:
+6.32%
6개월 성능:
+1,221%
1년 성능:
+516.67%
1일 변동 폭
$2.67
$2.91
1주일 범위
$2.67
$3.49
52주 변동 폭
$0.1253
$3.50
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.775 | 284.66M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
384.34 | 91.75B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.51 | 16.67B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
171.46 | 15.68B | 20.52B | 1.46B | 1.41B | 15.12 |
|
UHS
Universal Health Services Inc
|
189.39 | 12.27B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
121.54 | 12.19B | 5.51B | 494.70M | 386.40M | 4.84 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 개시 | BTIG Research | Buy |
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
Oncology Institute Inc 주식(TOI)의 최신 뉴스
Oncology Institute (TOI) Launches $50M Common Stock Offering | T - GuruFocus
The Oncology Institute (TOI) Plans $50 Million Stock Offering - GuruFocus
Oncology Institute Files $50 Million Shelf - marketscreener.com
Oncology institute director Brad Hively sells $5.67m in stock - Investing.com India
Oncology institute director Brad Hively sells $5.67m in stock By Investing.com - Investing.com Canada
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Growth in Short Interest - Defense World
The Oncology Institute (TOI) Set to Join Russell 2000 and 3000 i - GuruFocus
The Oncology Institute joins Russell 2000 and 3000 indexes - Investing.com
The Oncology Institute (TOI) Set to Join Russell 2000 and 3000 in 2025 | TOI Stock News - GuruFocus
The Oncology Institute, Inc. to Join Russell 2000® and Russell 3000® Indexes After 2025 Reconstitution - Nasdaq
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes - The Manila Times
Major Market Milestone: The Oncology Institute Secures Spot in Both Russell 2000 and 3000 Indexes - Stock Titan
Oncology Institute (NASDAQ:TOI) Trading Up 2.9% – Time to Buy? - Defense World
Oncology Institute Explores PIPE Financing Opportunity - MSN
Oncology Institute And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Oncology Institute Gains 17%, Insider Trades Reap Benefit - simplywall.st
BTIG Research Begins Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusi - GuruFocus
Oncology Institute’s Earnings Call: Strong Start to 2025 - TipRanks
Oncology Institute Narrows Q1 Loss, Reaffirms 2025 Outlook On Capitation And Pharmacy Growth - Nasdaq
BTIG sets $7 price target on The Oncology Institute stock By Investing.com - Investing.com Nigeria
BTIG Initiates Oncology Institute at Buy With $7 Price Target - marketscreener.com
BTIG sets $7 price target on The Oncology Institute stock - Investing.com
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusiastic Outlook | TOI Stock News - GuruFocus
The Oncology Institute’s Strong Q1 2025 Performance - TipRanks
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth By Investing.com - Investing.com South Africa
The Oncology Institute (TOI) Reports Q1 Earnings and Revenue Inc - GuruFocus
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth - Investing.com Australia
Oncology Institute Q1 2025 Earnings Call Transcript - MarketBeat
The Oncology Institute, Inc. Reports Strong Q1 2025 Financial Results and Strategic Growth Initiatives - Nasdaq
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer - The Manila Times
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year ... - Bluefield Daily Telegraph
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - GlobeNewswire
The Oncology Institute Taps Former Cigna National Oncology Director to Scale Value-Based Care Model - Stock Titan
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference - The Manila Times
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional ... - Eagle-Tribune
Leading Value-Based Oncology Group TOI Executives to Share Growth Strategy at B. Riley Conference - Stock Titan
Oncology Institute reports annual meeting outcomes By Investing.com - Investing.com Nigeria
The Oncology Institute to Present at Upcoming ASCO Annual - GlobeNewswire
Oncology Institute Holds Annual Stockholders Meeting - TipRanks
Oncology Institute reports annual meeting outcomes - Investing.com
Oncology Institute (TOI) Highlights Benefits of High-Value Cance - GuruFocus
Oncology Institute (TOI) Highlights Benefits of High-Value Cancer Care Model | TOI Stock News - GuruFocus
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates - marketscreener.com
Renaissance Technologies LLC Grows Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute COO Jeremy Castle Resigns - TipRanks
The Oncology Institute: Insiders Buy Up Big While Valuations Are Murky (NASDAQ:TOI) - Seeking Alpha
The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24% - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Shares Sold by Geode Capital Management LLC - Defense World
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.84%
자본화:
|
볼륨(24시간):